Today is July 01, 2024. All times in Eastern Daylight Time.
"Experience the Luxury of Japanese Tradition and Cuisine" Reservations for the New Inbound Experience Tour in Osaka's Tondabayashi Begin on June 1, 2024!
06/01/2024 - 10:00 AM
BUSINESS WIRE
Tempus Announces Expansion of Collaboration with AstraZeneca to Leverage Tempus Next to Support Guideline-directed Biomarker Testing in NSCLC
06/01/2024 - 09:30 AM
BUSINESS WIRE
Postmedia Announces Closing of Previously Announced Transaction with the Klein Group
06/01/2024 - 09:15 AM
BUSINESS WIRE
オムディアのRANベンダー・レポートでマべニアがトップに輝く
06/01/2024 - 09:15 AM
BUSINESS WIRE
Sally Hansen® and GLAAD Reprise Their Partnership for the 6th Year With a Launch That Celebrates the LGBTQ+ Community
06/01/2024 - 09:00 AM
BUSINESS WIRE
Ankyra Therapeutics Announces Trial in Progress Poster Presentation at 2024 ASCO Meeting and Approval of ANK-101 Phase 1 Protocol Amendment
06/01/2024 - 09:00 AM
BUSINESS WIRE
Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting
06/01/2024 - 08:10 AM
BUSINESS WIRE
Accutar Biotechnology Presents Phase 1 Data of AC699 Monotherapy in Patients with ER+ / HER2- Breast Cancer at ASCO 2024
06/01/2024 - 08:00 AM
BUSINESS WIRE
KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer
06/01/2024 - 08:00 AM
BUSINESS WIRE
Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma
06/01/2024 - 08:00 AM
BUSINESS WIRE
1
...
1345
1346
1347
1348
1349
1350
1351
1352
1353
1354
1355
« Previous
Next »